Nobel laureate David Baker, right, speaks with BioCentury's Simone Fishburn at the Life Science Innovation Northwest ...

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

The recent update to ISO 15223-1, formalized through Amendment 1:2025, ushers in a critical shift for medical device labeling ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

The industrially ravaged Gowanus Canal, long regarded as a symbol of urban environmental neglect, is being reimagined through ...

(AP) After nearly 12,500 years, scientists at Colossal Biosciences have revived the extinct dire wolf through genetic engineering ... They are a symbol of strength, courage, and the untamed ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

For over a decade, the intriguing concept of de-extinction has captivated both scientists and the public alike. The revival of long-gone species, once thought to be mere science fiction, is slowly ...

Please go ahead, sir. Thank you, operator. Good morning, everyone. And welcome to PDS Biotech's 2024 results and clinical program update call. I am joined on the call today by the following ...

Sana Biotechnology, Inc. (NASDAQ ... In that sense, SANA’s technology has both ex vivo and in vivo cell engineering platforms. These platforms essentially modify cells to repair or replace ...